We offer highly specific and unique monoclonal antibodies against the markers of neurodegenerative disease. Our portfolio includes different isoforms and phosphorylated forms of Tau (e.g. brain-derived Tau, p50-Tau, p181-Tau, p217-Tau), beta-Amyloid, alpha-Synuclein (total and pathological a-Synuclein), TDP43 and Prion Protein.